Drug intelligence / Profile preview

chloroprocaine

Development stage
Approved
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Infiltration, Peripheral Nerve Block, Epidural, Caudal, Intrathecal
01

Overview

Chloroprocaine is an ester-type local anesthetic primarily used for the production of local or regional anesthesia, including infiltration, peripheral nerve block, epidural, caudal, and subarachnoid (spinal) anesthesia in adults. It acts by binding to the alpha subunit on the cytoplasmic region of voltage-gated sodium channels in neuronal cell membranes, inhibiting sodium influx and thereby blocking nerve impulse conduction. This results in a reversible loss of sensation with a rapid onset (6–12 minutes) and short duration of action (up to 60 minutes). Chloroprocaine is especially favored for procedures requiring quick onset and short duration of anesthesia. At therapeutic doses it has minimal cardiovascular effects but can cause central nervous system stimulation or depression at toxic concentrations[2][3][4][5][8].

Brand names
NesacaineNesacaine-MPFClorotekal
Other names
chloroprocaine hydrochloride
02

Targets

NaV alpha (Voltage-gated sodium channel alpha subunit family)

Beyond the preview

Go deeper on chloroprocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chloroprocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call